Patented in 2012 and 2013 in Europe and the US, respectively, VelocImmune humanised mice are genetically modified mice that have unrearranged human immunoglobulin variable region gene segments at ...
Biotech company Regeneron (REGN) and French pharmaceutical giant Sanofi (SNY) today announced that Japan has granted ...